Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Pentoxifylline
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pentoxifylline 400mg modified-release tablets
0206040AGAAACAC
|
Pentoxifylline | Pentoxifylline | Cardiovascular System | 4,991 |
|
Trental 400 modified-release tablets
0206040AGBBAAAC
|
Trental | Pentoxifylline | Cardiovascular System | 506 |
|
Neotren MR 400mg tablets
0206040AGBCAAAC
|
Neotren | Pentoxifylline | Cardiovascular System | No data available |
|
Pentofin 400mg modified-release tablets
0206040AGBDAAAC
|
Pentofin | Pentoxifylline | Cardiovascular System | No data available |
|
Pentoxifylline 100mg/5ml oral solution
0206040AGAAAFAF
|
Pentoxifylline | Pentoxifylline | Cardiovascular System | No data available |
|
Pentoxifylline 100mg/5ml oral suspension
0206040AGAAAGAG
|
Pentoxifylline | Pentoxifylline | Cardiovascular System | No data available |
|
Pentoxifylline 200mg/5ml oral solution
0206040AGAAAEAE
|
Pentoxifylline | Pentoxifylline | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.